Interview with Prof. Dr. Jean-Marie Lehn
Dr. Jean-Marie Lehn is presently Professor Emeritus at the University of Strasbourg. He won the Nobel Prize in Chemistry in 1987 for his studies on the chemical basis of “molecular recognition”. Lehn collaborated with NormOxys a biotechnology company developing a new class of small molecule drugs used as cancer treatments. Together NormOxys with Prof. Lehn and his team of researchers developed and synthesized a novel anti-cancer agent. After testing the efficacy of the compound on several cancer animal models, NormOxys raised capital through venture capital firms and completed Phase I clinical trials on normal healthy volunteers in late 2010. Phase I results show that the novel anti-cancer agent is completely safe and nontoxic. The non-GMP material for the tox studies and the cGMP material for the Phase I studies was manufactured at CARBOGEN AMCIS, Switzerland.